In Ukraine, pharmaceutical provision of patients with pulmonary hypertension (PH) as a rare (orphan) disease is one of the important components of the State policy.
I. S. Datsenko +2 more
doaj +1 more source
Provision of medical organizations with pharmaceutical products: approaches for the improvement
The article is devoted to the development of organizational approaches to improve the system of supplying medical organizations with pharmacy products. It should be based on detailed analysis of external and internal environmental factors. The use of TEMPLES+IM analysis has been proposed to assess the influence of environmental factors.
Fatih R. Paigin, Elena P. Gladunova
openaire +1 more source
MODERN PROBLEMS OF MEDICAL AND PHARMACEUTICAL CARE FOR OCCUPATIONAL DISEASES
Comprehensive medical and pharmaceutical studies of the problem of occupational morbidity in Kuzbass were not carried out enough, while the results obtained will contribute to solving the problem of occupational diseases (OD), maintaining the health of ...
Андрей Георгиевич Петров +4 more
doaj
The right to health as the basis for universal health coverage : a cross-national analysis of national medicines policies of 71 countries [PDF]
Persistent barriers to universal access to medicines are limited social protection in the event of illness, inadequate financing for essential medicines, frequent stock-outs in the public sector, and high prices in the private sector.
Alexandrov, Nikita V +2 more
core +2 more sources
Practice, Skill Mix, and Education: The Evolving Role of Pharmacy Technicians in Great Britain [PDF]
Pharmacy technicians’ roles are rapidly evolving in Great Britain (GB) as they undertake more extended activities with increased autonomy across the different pharmacy sectors.
Boughen, Melanie, Fenn, Tess
core +1 more source
The Newest \u27War on Drugs:\u27 Regulating Pharmaceuticals through State Litigation [PDF]
State-driven litigation has had increasing influence in the development of national policy in recent years, including in national health policy.
Nolette, Paul
core +1 more source
Delayed Access to Generic Medicine: A Comment on the Hatch-Waxman Act and the Approval Bottleneck [PDF]
Prescription drug costs can be astronomical. The advent of generic drugs, which sell at substantially lower prices than their brand-name counterparts, can save consumers billions of dollars per year. The Hatch-Waxman Act, which governs the introduction
Patel, Ankur N.
core +1 more source
Background Although pharmaceutical care has tangible positive importance in ensuring patient pharmacotherapy safety, its provision encounters several barriers.
Mekdes Kiflu +8 more
doaj +1 more source
Indian pharmaceutical patent prosecution: The changing role of Section 3(d).
India, like many developing countries, only recently began to grant pharmaceutical product patents. Indian patent law includes a provision, Section 3(d), which tries to limit grant of "secondary" pharmaceutical patents, i.e.
Bhaven N Sampat, Kenneth C Shadlen
doaj +1 more source
Korea, the Pharmaceutical Industry and Non-Commercial Use in the TRIPS Agreement [PDF]
In 2002, a number of associations requested the Korean Patent Office to issue a compulsory license for the manufacture of a drug under the Korean patent provision which permits the issue of compulsory licensing for public non-commercial use.
Shanker, Daya
core

